ASBM Exhibits at June Oncology, Pharmacy Conferences

June 15, 2017

On June 3-5th, ASBM exhibited at the American Society of Clinical Oncologists (ASCO) Annual Meeting in Chicago, IL. There ASBM Chairman Harry L. Gewanter, MD spoke with many physicians, patient advocates and manufacturers about ASBM’s worldwide advocacy on behalf of patients. ASBM shared a booth with Steering Committee member Global Colon Cancer Association, represented by […]

Read More


ASBM Presents With CT State Medical Society

June 1, 2017

On May 30th, in partnership with the Connecticut State Medical Society, ASBM presented a 2-hour Continuing Medical Education (CME) course entitled “Biosimilars: New Choices, New Challenges”. The event began with remarks by CSMS President Jeff Gordon, MD, who is Medical Director of Hematology-Oncology Services at Day-Kimball Hospital in Putnam, CT. Dr. Gordon emphasized the great excitement […]

Read More


What a Difference a Year Makes!

November 18, 2016

Philip J. Schneider, MS FASHP Associate Dean, University of Arizona College of Pharmacy ASBM Advisory Board Chair This past weekend it was my honor to participate in a continuing education course for 100 New York pharmacists on the topic of biologic medicines and biosimilars, including safety and regulatory considerations which affect pharmacy practice.  The 5-hour […]

Read More


ASBM Conducts CE Course for 100 NY Pharmacists

November 14, 2016

On November 13th, ASBM conducted a 5-hour Continuing Education (CE) course for 100 New York pharmacists in Queens, NY. The course, entitled “Biosimilars and Biologics- Regulatory and Practice Issues for Pharmacists” was presented in conjunction with the Long Island University College of Pharmacy (LIU-Pharmacy). The course was a follow-up to the 5-hour course ASBM and LIU-Pharmacy presented in March […]

Read More


ASBM Latin American Chapter Joins Biosimilars Forum in Brazil

September 28, 2016

SÁO PAULO, BRAZIL- The Latin American Chapter of the Alliance for Safe Biologic Medicines (ASBM) and the Global Colon Cancer Association (GCCA) today participated in a biologics and biosimilars forum in Sáo Paulo, Brazil. The chapter is comprised of eight patient organizations representing a variety of disease groups including multiple forms of cancer, hepatitis, and […]

Read More


ASBM Presents at University of the Sciences in Philadelphia

September 15, 2016

On September 15th, 2016, ASBM held an educational forum at the University of the Sciences in Philadelphia (USciences). The program drew 50 attendees comprised of pharmacists, faculty members, pharmacy students. The program began with an introduction to biosimilars from USciences Associate Professor of Pharmaceutical Sciences Dr. Zhiyu Li. Dr. Li is Director of Undergraduate Pharmacology/Toxicology Program, where he […]

Read More


ASBM and MD State Medical Society Host Biosimilars Forum in Baltimore

July 25, 2016

On Friday, July 22nd, The Alliance for Safe Biologic Medicines and MedChi, the Maryland State Medical Society co-hosted a forum entitled “Biosimilars: New Choices, New Challenges”. The event was attended by more than 45 physicians, legislators, patient advocates, healthcare workers, and others. MedChi’s CEO, Gene Ransom III began the forum with a discussion of the importance of biosimilars […]

Read More


ASBM Promotes High Approval Standards, Memorable Names at DIA 2016

July 6, 2016

ASBM was an exhibitor during the 52nd Annual meeting of the Drug Information Association (DIA) held June 26th-30th in Philadelphia. ASBM members and staff discussed biosimilars policy with attendees, including the need for the FDA to maintain high standards for safety and efficacy when approving biosimilars. More than 65 attendees, including clinical researchers, physicians, pharmacists, […]

Read More


ASBM Presents at Latin American Forum on Biosimilars

July 6, 2016

On June 29th, ASBM Chairman Harry L. Gewanter, MD and ASBM Steering Committee Member Andrew Spiegel, Executive Director of the Global Colon Cancer Association, gave presentations at the 6th Latin American Forum on Biosimilars, held in Brasília, Brazil. The event was also the 7th Brazilian Forum on Biosimilars. The event was attended by more than 500 […]

Read More


ASBM Presents to New York State Pharmacy Society

June 4, 2016

ASBM Presents to New York State Pharmacy Society  On June 3rd, ASBM’s Advisory Board Chair Dr. Philip Schneider, Associate Dean at the University of Arizona’s College of Pharmacy, presented to the Pharmacy Society of the State of New York (PSSNY) at a forum held at the Albany College of Pharmacy. Dr. Schneider discussed how biologics […]

Read More